Key points from article :
SiPhox Health developed an advanced blood testing system using silicon photonic chip technology to put a lab-grade health testing device in every home.
Enables patients and their doctors to get lots of data points to better help make real-time health decisions.
Offers a test kit for 17 biomarkers, with basic panel of inflammation, cardiovascular health, metabolic fitness and hormone balance.
On a subscription basis, kits are $95 with a monthly membership of $16 that includes perks like continuous glucose monitors and personalized biohacking tools.
Currently, it is running the tests using mail-in samples and conventional technology.
Price of its future offering, the SiPhox Home product, will be subscription-based at less than $100 per month.
Working toward getting the SiPhox Home product through U.S. FDA clearance in the next year.
SiPhox Home product will offer proteins and hormone tests from a finger-prick blood sample, with results in five minutes or less.
Boosted by a $27 million round of funding that includes $10 million in seed and $17 million in new Series A capital.
The Series A funding to expand its team and its current business offerings.
“We are finding early signs of chronic diseases, like pre-diabetes, in about 20% of the tests,” - Michael Dubrovsky, co-founder of SiPhox.
